Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Appl Microbiol Biotechnol ; 103(12): 4869-4880, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31053912

RESUMEN

The yeast Saccharomyces cerevisiae has been widely used as a model system for studying the physiological and pharmacological action of small-molecular drugs. Here, a heterozygous diploid S. cerevisiae strain QSS4 was generated to determine whether drugs could induce chromosomal instability by determining the frequency of mitotic recombination. Using the combination of a custom SNP microarray and yeast screening system, the patterns of chromosomal instability induced by drugs were explored at the whole genome level in QSS4. We found that Zeocin (a member of the bleomycin family) treatment increased the rate of genomic alterations, including aneuploidy, loss of heterozygosity (LOH), and chromosomal rearrangement over a hundred-fold. Most recombination events are likely to be initiated by DNA double-stand breaks directly generated by Zeocin. Another remarkable finding is that G4-motifs and low GC regions were significantly underrepresented within the gene conversion tracts of Zeocin-induced LOH events, indicating that certain DNA regions are less preferred Zeocin-binding sites in vivo. This study provides a novel paradigm for evaluating genetic toxicity of small-molecular drugs using yeast models.


Asunto(s)
Inestabilidad Cromosómica/efectos de los fármacos , Cromosomas Fúngicos , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/genética , Bibliotecas de Moléculas Pequeñas/farmacología , Aneuploidia , Bleomicina/farmacología , División Celular , Reordenamiento Génico , Inestabilidad Genómica , Pérdida de Heterocigocidad , Recombinación Genética
2.
Fungal Genet Biol ; 89: 102-113, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26701311

RESUMEN

Small peptides formed from non-ribosomal peptide synthetases (NRPS) are bioactive molecules produced by many fungi including the genus Aspergillus. A subset of NRPS utilizes tryptophan and its precursor, the non-proteinogenic amino acid anthranilate, in synthesis of various metabolites such as Aspergillus fumigatus fumiquinazolines (Fqs) produced by the fmq gene cluster. The A. fumigatus genome contains two putative anthranilate synthases - a key enzyme in conversion of anthranilic acid to tryptophan - one beside the fmq cluster and one in a region of co-linearity with other Aspergillus spp. Only the gene found in the co-linear region, trpE, was involved in tryptophan biosynthesis. We found that site-specific mutations of the TrpE feedback domain resulted in significantly increased production of anthranilate, tryptophan, p-aminobenzoate and fumiquinazolines FqF and FqC. Supplementation with tryptophan restored metabolism to near wild type levels in the feedback mutants and suggested that synthesis of the tryptophan degradation product kynurenine could negatively impact Fq synthesis. The second putative anthranilate synthase gene next to the fmq cluster was termed icsA for its considerable identity to isochorismate synthases in bacteria. Although icsA had no impact on A. fumigatus Fq production, deletion and over-expression of icsA increased and decreased respectively aromatic amino acid levels suggesting that IcsA can draw from the cellular chorismate pool.


Asunto(s)
Antranilato Sintasa/genética , Aspergillus fumigatus/genética , Aspergillus fumigatus/metabolismo , Retroalimentación Fisiológica , Proteínas Fúngicas/genética , Metabolismo Secundario/genética , Triptófano/metabolismo , Secuencia de Aminoácidos , Aminoácidos , Antranilato Sintasa/metabolismo , Escherichia coli/genética , Proteínas Fúngicas/metabolismo , Familia de Multigenes , Mutación , Péptido Sintasas/genética , Quinazolinas/metabolismo , ortoaminobenzoatos/metabolismo
3.
Bioresour Technol ; 134: 87-93, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23500564

RESUMEN

The optimization, purification and characterization of bioflocculant produced by Paenibacillus elgii B69 were investigated. The bioflocculant was an exopolysaccharide composed of glucose, glucuronic acid, mannose and xylose. The maximum bioflocculant production was about 25.63 g/L achieved with sucrose at 51.35 g/L, peptone at 6.78 g/L and yeast extract at 0.47 g/L optimized by response-surface methodology. In addition, a series of experiments was performed to investigate the flocculation activities towards kaolin clay, dyeing pigment, heavy metal ion, and real wastewater and the result indicated the new bioflocculant had high activities towards all the tested pollutions. These results showed its great potential for water pretreatment used in industry.


Asunto(s)
Paenibacillus/metabolismo , Polisacáridos/química , Aguas Residuales/microbiología , Purificación del Agua/métodos , Adsorción , Biodegradación Ambiental/efectos de los fármacos , Carbono/farmacología , Color , Espacio Extracelular/efectos de los fármacos , Espacio Extracelular/metabolismo , Floculación , Iones , Metales Pesados/aislamiento & purificación , Nitrógeno/farmacología , Paenibacillus/efectos de los fármacos , Reproducibilidad de los Resultados , Contaminantes Químicos del Agua/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA